News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
464,079 Results
Type
Article (51287)
Company Profile (93)
Press Release (412699)
Multimedia
Podcasts (28)
Webinars (10)
Section
Business (131191)
Career Advice (1611)
Deals (20297)
Drug Delivery (52)
Drug Development (58286)
Employer Resources (126)
FDA (9459)
Job Trends (10150)
News (220120)
Policy (17887)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2708)
Academic (1)
Accelerated approval (4)
Adcomms (11)
Allergies (59)
Alliances (37597)
ALS (70)
Alzheimer's disease (1220)
Antibody-drug conjugate (ADC) (86)
Approvals (9501)
Artificial intelligence (189)
Autoimmune disease (16)
Automation (9)
Bankruptcy (138)
Best Places to Work (8048)
BIOSECURE Act (11)
Biosimilars (51)
Biotechnology (60)
Bladder cancer (43)
Brain cancer (24)
Breast cancer (190)
Cancer (1660)
Cardiovascular disease (124)
Career advice (1347)
Career pathing (27)
CAR-T (108)
Cell therapy (288)
Cervical cancer (15)
Clinical research (46443)
Collaboration (657)
Compensation (82)
Complete response letters (7)
COVID-19 (2168)
CRISPR (30)
C-suite (148)
Cystic fibrosis (71)
Data (1660)
Decentralized trials (2)
Denatured (14)
Depression (30)
Diabetes (183)
Diagnostics (4373)
Digital health (11)
Diversity (7)
Diversity, equity & inclusion (35)
Drug discovery (105)
Drug pricing (62)
Drug shortages (17)
Duchenne muscular dystrophy (60)
Earnings (46805)
Editorial (27)
Employer branding (18)
Employer resources (110)
Events (57703)
Executive appointments (489)
FDA (10259)
Featured Employer (27)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (542)
Gene editing (65)
Generative AI (16)
Gene therapy (210)
GLP-1 (516)
Government (2729)
Grass and pollen (4)
Guidances (37)
Healthcare (12864)
Huntington's disease (13)
IgA nephropathy (13)
Immunology and inflammation (73)
Indications (20)
Infectious disease (2274)
Inflammatory bowel disease (105)
Inflation Reduction Act (6)
Influenza (43)
Intellectual property (60)
Interviews (310)
IPO (9119)
IRA (31)
Job creations (2419)
Job search strategy (1161)
Kidney cancer (7)
Labor market (26)
Layoffs (281)
Leadership (13)
Legal (3359)
Liver cancer (43)
Lung cancer (228)
Lymphoma (111)
Machine learning (5)
Management (40)
Manufacturing (187)
MASH (55)
Medical device (7478)
Medtech (7481)
Mergers & acquisitions (11560)
Metabolic disorders (439)
Multiple sclerosis (63)
NASH (17)
Neurodegenerative disease (60)
Neuropsychiatric disorders (13)
Neuroscience (1616)
NextGen: Class of 2025 (4306)
Non-profit (4011)
Northern California (1619)
Now hiring (24)
Obesity (210)
Opinion (159)
Ovarian cancer (61)
Pain (60)
Pancreatic cancer (57)
Parkinson's disease (117)
Partnered (19)
Patents (131)
Patient recruitment (77)
Peanut (33)
People (39375)
Pharmaceutical (27)
Pharmacy benefit managers (12)
Phase I (13811)
Phase II (20049)
Phase III (16054)
Pipeline (936)
Policy (93)
Postmarket research (2137)
Preclinical (7108)
Press Release (67)
Prostate cancer (73)
Psychedelics (23)
Radiopharmaceuticals (176)
Rare diseases (243)
Real estate (4274)
Recruiting (49)
Regulatory (13148)
Reports (32)
Research institute (2538)
Resumes & cover letters (226)
Rett syndrome (1)
RNA editing (1)
RSV (29)
Schizophrenia (54)
Series A (91)
Series B (51)
Service/supplier (11)
Sickle cell disease (38)
Southern California (1423)
Special edition (13)
Spinal muscular atrophy (118)
Sponsored (23)
Startups (2584)
Stomach cancer (6)
Supply chain (36)
Tariffs (15)
The Weekly (14)
United States (14315)
Vaccines (559)
Venture capitalists (19)
Weight loss (127)
Women's health (23)
Worklife (13)
Date
Today (87)
Last 7 days (433)
Last 30 days (1643)
Last 365 days (21811)
2025 (6471)
2024 (23414)
2023 (27057)
2022 (37067)
2021 (39623)
2020 (37099)
2019 (31812)
2018 (24108)
2017 (22521)
2016 (22267)
2015 (26319)
2014 (19795)
2013 (17236)
2012 (17338)
2011 (18284)
2010 (16802)
Location
Africa (640)
Alabama (45)
Alaska (6)
Arizona (110)
Arkansas (6)
Asia (29277)
Australia (5544)
California (3679)
Canada (1318)
China (357)
Colorado (156)
Connecticut (171)
Delaware (79)
Europe (70513)
Florida (590)
Georgia (146)
Idaho (32)
Illinois (345)
India (24)
Indiana (211)
Iowa (8)
Japan (132)
Kansas (67)
Kentucky (16)
Louisiana (8)
Maine (20)
Maryland (575)
Massachusetts (2660)
Michigan (153)
Minnesota (211)
Mississippi (1)
Missouri (57)
Montana (21)
Nebraska (13)
Nevada (31)
New Hampshire (30)
New Jersey (1178)
New Mexico (28)
New York (1224)
North Carolina (665)
North Dakota (5)
Northern California (1619)
Ohio (131)
Oklahoma (8)
Oregon (14)
Pennsylvania (773)
Puerto Rico (4)
Rhode Island (20)
South America (770)
South Carolina (15)
Southern California (1423)
Tennessee (50)
Texas (560)
Utah (96)
Virginia (96)
Washington D.C. (47)
Washington State (388)
West Virginia (1)
Wisconsin (34)
464,079 Results for "illingworth research group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Analysis Group Researchers Coauthor First Study Revealing Age-Specific Incidence of Pneumococcal Disease in Young Children
Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have coauthored the first large-scale US study of how pneumococcal disease (PD) manifests by age group, insurance status, and sociodemographic characteristics in young children aged 0–2 years during the study period (1998–2019).
June 6, 2024
·
2 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
December 20, 2024
·
4 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
BANOOK GROUP DEPLOYS GROWTH STRATEGY WITH ACQUISITIONS OF KEOSYS AND B.RESEARCH
Nancy, France, June 11, 2024 - Banook Group, global provider of technology and services for clinical trial operators, today announces two strategic acquisitions that enhance its offerings in central imaging and eCOA.
June 13, 2024
·
5 min read
Bio NC
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021
The Illingworth Research Group, a Syneos Health® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade.
April 30, 2021
·
3 min read
Press Releases
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025
April 25, 2025
·
2 min read
Press Releases
Devonian Health Group Reports Second Quarter 2025 Financial Results
April 15, 2025
·
6 min read
Press Releases
Duchesnay Pharmaceutical Group wins 2024 Life Sciences Innovation Award from ADRIQ, the Association for the Development of Research and Innovation of Quebec
November 22, 2024
·
5 min read
Business
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its Virtual Control Groups (VCG) initiative with Sanofi.
June 4, 2024
·
3 min read
1 of 46,408
Next
